AMGN · Categories · Downgrades
AMGN - Analyst downgrades
Amgen Inc. (AMGN) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for AMGN
- Amgen downgraded by Erste GroupErste Group downgraded Amgen from Buy to Hold
- Amgen downgraded by Bernstein with a new price targetBernstein downgraded Amgen from Outperform to Mkt Perform and set a new price target of $335.00
- Amgen downgraded by Truist with a new price targetTruist downgraded Amgen from Buy to Hold and set a new price target of $333.00 from $320.00 previously
- Amgen downgraded by Wells Fargo with a new price targetWells Fargo downgraded Amgen from Overweight to Equal Weight and set a new price target of $335.00 from $320.00 previously
- Amgen downgraded by Leerink Partners with a new price targetLeerink Partners downgraded Amgen from Outperform to Market Perform and set a new price target of $318.00 from $324.00 previously
- Amgen downgraded by Barclays with a new price targetBarclays downgraded Amgen from Equal Weight to Underweight and set a new price target of $234.00
- Amgen downgraded by BofA Securities with a new price targetBofA Securities downgraded Amgen from Buy to Neutral and set a new price target of $255.00 from $285.00 previously
- Amgen downgraded by Daiwa Capital with a new price targetDaiwa Capital downgraded Amgen from Outperform to Neutral and set a new price target of $220.00
- Amgen downgraded by Morgan Stanley with a new price targetMorgan Stanley downgraded Amgen from Overweight to Equal-Weight and set a new price target of $251.00 from $280.00 previously
- Amgen downgraded by Atlantic Equities with a new price targetAtlantic Equities downgraded Amgen from Neutral to Underweight and set a new price target of $200.00